Alzahrani, Mashari
Stober, Carol
Liu, Michelle
Awan, Arif
Ng, Terry L.
Pond, Gregory
Alshamsan, Bader
Vandermeer, Lisa
Clemons, Mark https://orcid.org/0000-0002-0738-2713
Article History
Received: 29 June 2021
Accepted: 18 November 2021
First Online: 21 January 2022
Declarations
:
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the Ontario Cancer Research Ethics Board and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. All data has been de-identified to protect the identities of subjects involved in the research.
: Integrated verbal consent was obtained from all trial participants included in the study.
: All participants consented to de-identified publication of aggregate study results.
: AA reports personal fees (honoraria) from Apotex, Eli Lily, Exact Sciences, Exactis, Novartis, Pfizer, and Roche outside the submitted work. TN reports personal fees (honoraria) from ARIAD, Takeda, and Boehringer-Ingelheim, outside the submitted work. GRP reports personal fees (honoraria) from Astra-Zeneca and Merck outside the submitted work, as well as a family member who works for Roche and owns stock in Roche. All other authors declare no competing interests.